搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Nitrosococcus oceani V-type ATP synthase subunit E (atpE) CSB-YP668369NAAI
CSB-EP668369NAAI
CSB-BP668369NAAI
CSB-MP668369NAAI
CSB-EP668369NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani GTP cyclohydrolase folE2 (folE2) CSB-YP668370NAAI
CSB-EP668370NAAI
CSB-BP668370NAAI
CSB-MP668370NAAI
CSB-EP668370NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B (gatB) CSB-YP668371NAAI
CSB-EP668371NAAI
CSB-BP668371NAAI
CSB-MP668371NAAI
CSB-EP668371NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Chaperone protein htpG (htpG), partial CSB-YP668372NAAI
CSB-EP668372NAAI
CSB-BP668372NAAI
CSB-MP668372NAAI
CSB-EP668372NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Phosphate acyltransferase (plsX) CSB-YP668373NAAI
CSB-EP668373NAAI
CSB-BP668373NAAI
CSB-MP668373NAAI
CSB-EP668373NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Ferrochelatase (hemH) CSB-YP668374NAAI
CSB-EP668374NAAI
CSB-BP668374NAAI
CSB-MP668374NAAI
CSB-EP668374NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani 4-hydroxybenzoate octaprenyltransferase (ubiA), partial CSB-YP668375NAAI
CSB-EP668375NAAI
CSB-BP668375NAAI
CSB-MP668375NAAI
CSB-EP668375NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Phenylalanine--tRNA ligase beta subunit (pheT), partial CSB-YP668376NAAI
CSB-EP668376NAAI
CSB-BP668376NAAI
CSB-MP668376NAAI
CSB-EP668376NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani NADH-quinone oxidoreductase subunit C/D (nuoC), partial CSB-YP668377NAAI
CSB-EP668377NAAI
CSB-BP668377NAAI
CSB-MP668377NAAI
CSB-EP668377NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Ribosomal protein L11 methyltransferase (prmA) CSB-YP668378NAAI
CSB-EP668378NAAI
CSB-BP668378NAAI
CSB-MP668378NAAI
CSB-EP668378NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani N- (5'-phosphoribosyl)anthranilate isomerase (trpF) CSB-YP668379NAAI
CSB-EP668379NAAI
CSB-BP668379NAAI
CSB-MP668379NAAI
CSB-EP668379NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Cytochrome c-type biogenesis protein CcmE (ccmE), partial CSB-YP668380NAAI
CSB-EP668380NAAI
CSB-BP668380NAAI
CSB-MP668380NAAI
CSB-EP668380NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Glycine cleavage system H protein (gcvH) CSB-YP668381NAAI
CSB-EP668381NAAI
CSB-BP668381NAAI
CSB-MP668381NAAI
CSB-EP668381NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Aspartate 1-decarboxylase (panD) CSB-YP668382NAAI
CSB-EP668382NAAI
CSB-BP668382NAAI
CSB-MP668382NAAI
CSB-EP668382NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Enolase (eno) CSB-YP668383NAAI
CSB-EP668383NAAI
CSB-BP668383NAAI
CSB-MP668383NAAI
CSB-EP668383NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Elongation factor Ts (tsf) CSB-YP668384NAAI
CSB-EP668384NAAI
CSB-BP668384NAAI
CSB-MP668384NAAI
CSB-EP668384NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Protein-L-isoaspartate O-methyltransferase 1 (pcm1) CSB-YP668385NAAI
CSB-EP668385NAAI
CSB-BP668385NAAI
CSB-MP668385NAAI
CSB-EP668385NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Phosphate import ATP-binding protein PstB 1 (pstB1) CSB-YP668386NAAI
CSB-EP668386NAAI
CSB-BP668386NAAI
CSB-MP668386NAAI
CSB-EP668386NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani Peptide chain release factor 1 (prfA) CSB-YP668387NAAI
CSB-EP668387NAAI
CSB-BP668387NAAI
CSB-MP668387NAAI
CSB-EP668387NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosococcus oceani UPF0301 protein Noc_0368 (Noc_0368) CSB-YP668388NAAI
CSB-EP668388NAAI
CSB-BP668388NAAI
CSB-MP668388NAAI
CSB-EP668388NAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>